EBAMed: Funding, Investors & Team (Sep 2026)
EBAMed SA is a Swiss startup based in Geneva whose mission is to enable safe and effective non-invasive treatments of heart arrhythmias with protontherapy. The company is currently developing a medical device to enable non-invasive heart motion imaging and real-time synchronization of the therapeutic beam. This device consists in both hardware and software components and expands treatment possibilities for existing protontherapy centres, enabling them for the first time to treat heart patients.
EBAMed has raised $17.5M across 3 funding rounds on record, the most recent a Series A of $1.7M announced in Jan 2025.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
EBAMed Company Profile and Key Stats
Latest funding round on record: Jan 2025.
EBAMed Funding Rounds
EBAMed raised $100k in a Debt Financing announced in Sep 2022.
9 months later, a Series A of $15.7M was announced in Jun 2023.
1.6 years later, a Series A of $1.7M was announced in Jan 2025.
EBAMed Founders and Leadership Team
Contact details for the EBAMed team: 1 of 1 has an email address on file.
Start 14-day free trial →EBAMed Funding Compared to Other Health Care Startups
EBAMed's latest round of $1.7M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like EBAMed in Health Care and Geneva
Companies Similar to EBAMed
MoleSense is to provide a wearable skin sensor to help monitor high-risk pregnancies.
CeQur Simplicity helps people with diabetes by developing drug-delivery devices. They develop bolus insulin…
Calmea develops advanced contactless sensing systems that invisibly track sleep and automatically modify…
NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for…
UNBOOUND is a medtech company and university spin-off (The Rockefeller University and University of Geneva)…
Christina Vallgren and Marcus Palm, two physicists from CERN, co-founded Terapet along with Professor Raymond…
Axmed is a company that specializes in serving low and middle-income countries (LMICs), with the goal of…
Babylat is an enricher device is the first automated, small-scale tabletop device for the protein enrichment…
Altiscreen is creating and producing cutting-edge, portable drug-of-abuse detection systems. With the use of…
Vivent provides growers, breeders and agrochem companies with actionable information direct from plants…
Multiwave develops breakthrough Magnetic Resonance Imaging and Positron Emission Tomography devices. Founded…
EBAMed Funding FAQs
What does EBAMed do?
EBAMed SA is a Swiss startup based in Geneva whose mission is to enable safe and effective non-invasive treatments of heart arrhythmias with protontherapy. The company is currently developing a medical device to enable non-invasive heart motion imaging and real-time synchronization of the therapeutic beam. This device consists in both hardware and software components and expands treatment possibilities for existing protontherapy centres, enabling them for the first time to treat heart patients.
How much funding has EBAMed raised?
EBAMed has raised $17.5M across 3 rounds on record. The most recent is a Series A of $1.7M announced in Jan 2025.
When did EBAMed last raise funding?
EBAMed's most recent funding round on record is a Series A of $1.7M, announced in Jan 2025.
Who founded EBAMed?
FundedIQ lists Adriano Garonna (Founder) at EBAMed.
Where is EBAMed headquartered?
EBAMed is based in Geneva, Geneve, Switzerland.
How many employees does EBAMed have?
EBAMed is in the 1-10 employee band.
How does EBAMed's funding compare to other Health Care startups?
EBAMed's latest round of $1.7M is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's EBAMed Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for EBAMed is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.